Aldeyra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference

20:00 EDT 3 Aug 2016 | Marketwired

LEXINGTON, MA -- (Marketwired) -- 08/04/16 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company focused on the development of products to treat diseases related to aldehydes, today announced that Todd C. Brady, M.D., Ph.D., President and CEO of Aldeyra, will present at the Canaccord Genuity Annual Growth Conference on August 11, 2016 at the InterContinental in Boston, Massachusetts.

Canaccord Genuity Annual Growth Conference

Thursday, August 11, 2016

12:00 PM

About Aldeyra Therapeutics

Aldeyra Therapeutics, Inc. is a biotechnology company devoted to improving lives by inventing, developing and commercializing products that treat diseases thought to be related to endogenous aldehydes, a naturally occurring class of pro-inflammatory and toxic molecules. Aldeyra's lead product candidate, NS2, is an aldehyde trap in development for ocular inflammation, as well as for Sjögren-Larsson Syndrome and Succinic Semi-Aldehyde Dehydrogenase Deficiency, two inborn errors of aldehyde metabolism. NS2 has not been approved for sale in the U.S. or elsewhere.

Corporate Contact: Stephen Tulipano Aldeyra Therapeutics, Inc. Tel: +1 781-761-4904 ext. 205 Investor Contact: Chris Brinzey Westwicke Partners Tel: 339-970-2843 NEXT ARTICLE

More From BioPortfolio on "Aldeyra Therapeutics to Present at the Canaccord Genuity Annual Growth Conference "

Quick Search


Relevant Topics

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...